Gleostine Alternatives Compared
| Gleostine (lomustine) | Lomustine | Everolimus |
|
|---|
| Gleostine (lomustine) | Lomustine | Everolimus |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Brain Tumor, Anaplastic Oligodendroglioma, Hodgkin's Lymphoma. Gleostine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Brain Tumor, Anaplastic Oligodendroglioma, Hodgkin's Lymphoma. Lomustine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neuroendocrine Tumors, Breast Cancer, Tuberous Sclerosis Complex, Brain Tumor, Organ Transplant - Rejection Prophylaxis, Pancreatic Cancer, Renal Angiomyolipoma, Renal Cell Carcinoma... View more |
Related suggestions Brain Tumor
|
|||||||
| More about Gleostine (lomustine) | More about Lomustine | More about Everolimus | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Everolimus has an average rating of 5.6 out of 10 from a total of 29 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 38% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Gleostine side effects |
View all Lomustine side effects |
View all Everolimus side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
Lower cost generic |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Everolimus prices |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
||||||||
| Brand Names | ||||||||||
| Other lomustine brands include: CCNSB Capsules, CeeNU | CCNSB Capsules, CeeNU, Gleostine | Afinitor, Afinitor Disperz, Torpenz, Zortress | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
72 hours |
72 hours |
35 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 284 drugs are known to interact with Gleostine:
|
A total of 284 drugs are known to interact with Lomustine:
|
A total of 547 drugs are known to interact with Everolimus:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
August 04, 1976 |
August 04, 1976 |
March 30, 2009 |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.